What is hla b27

Last updated: April 1, 2026

Quick Answer: HLA B27 is a genetic marker representing a specific type of Human Leukocyte Antigen found on cell surfaces. It's associated with increased susceptibility to certain autoimmune diseases, particularly ankylosing spondylitis and reactive arthritis.

Key Facts

Understanding HLA B27

HLA B27 is a specific type of Human Leukocyte Antigen (HLA), which are proteins found on the surface of cells throughout the body. HLA molecules play a crucial role in the immune system by presenting antigens to immune cells. HLA B27 is a particular variant of these proteins that's encoded by a specific genetic sequence. While most people carry different HLA types, approximately 6-8% of the population carries HLA B27, and this genetic marker is significantly associated with certain autoimmune and inflammatory conditions.

Role in the Immune System

HLA B27 functions as an antigen-presenting molecule on cell surfaces, showing fragments of proteins to immune cells called cytotoxic T lymphocytes. In individuals with autoimmune diseases, the immune system may misidentify self-antigens as threats when presented by HLA B27, leading to an autoimmune response. The mechanism by which HLA B27 specifically predisposes to certain diseases is still being researched, but appears to involve both the genetic presentation of antigens and molecular mimicry with certain bacteria.

Associated Diseases

HLA B27 is most strongly associated with:

Genetic Testing and Diagnosis

HLA B27 genetic testing involves a blood test that identifies the presence of the HLA B27 protein. Testing is typically performed when patients present with symptoms suggesting an HLA B27-associated condition, such as inflammatory back pain, arthritis, or uveitis. A positive HLA B27 test result supports the diagnosis of conditions like ankylosing spondylitis but is not diagnostic alone; clinical presentation and other diagnostic criteria must also be considered.

Implications and Risk

Having HLA B27 does not guarantee disease development. Many individuals carrying the HLA B27 gene never develop any associated condition. The presence of HLA B27 appears to be a genetic predisposition factor rather than a definitive cause. Environmental factors, including infections, lifestyle, and additional genetic factors, likely play important roles in whether individuals with HLA B27 develop autoimmune diseases.

Population Variation

HLA B27 prevalence varies significantly among different populations. It's more common in Northern European and North American populations (6-8%) compared to African populations (0.5-1%) and Asian populations (0.1-0.5%). This variation may partly explain differences in disease prevalence among populations, though environmental and lifestyle factors also contribute significantly to disease development.

Related Questions

What is ankylosing spondylitis and how is it related to HLA B27?

Ankylosing spondylitis is a chronic inflammatory disease affecting the spine and joints, causing progressive stiffness and pain. HLA B27 is strongly associated with AS, being present in about 90% of patients. However, not all HLA B27-positive individuals develop AS, indicating that genetic predisposition alone isn't sufficient.

What does a positive HLA B27 test mean?

A positive HLA B27 test indicates the presence of the HLA B27 genetic marker. In the context of symptoms suggesting an autoimmune condition, it supports diagnosis. However, a positive test alone doesn't mean you will develop disease, as many HLA B27-positive individuals remain healthy.

Can HLA B27 be treated or cured?

HLA B27 itself cannot be treated or cured as it's a genetic marker. However, conditions associated with HLA B27, such as ankylosing spondylitis, can be managed with medications, physical therapy, and lifestyle modifications to reduce inflammation and maintain joint function.

Sources

  1. Wikipedia - HLA-B27CC-BY-SA-4.0
  2. National Center for Biotechnology InformationPublic Domain